Gonadal damage from 131I therapy for thyroid cancer
- 30 August 2002
- journal article
- editorial
- Published by Wiley in Clinical Endocrinology
- Vol. 57 (3) , 313-314
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancerPostgraduate Medical Journal, 2002
- 131I Therapy for Differentiated Thyroid Cancer Leads to an Earlier Onset of Menopause: Results of a Retrospective StudyThe Journal of Clinical Endocrinology & Metabolism, 2001
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2001
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2001
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994
- Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid CancerEndocrinology and Metabolism Clinics of North America, 1990
- Temporary Ovarian Failure in Thyroid Cancer Patients after Thyroid Remnant Ablation with Radioactive IodineThe Journal of Clinical Endocrinology & Metabolism, 1989
- TESTICULAR DAMAGE AFTER RADIOACTIVE IODINE (I‐131) THERAPY FOR THYROID CANCERClinical Endocrinology, 1983
- Azoospermia after iodine-131 treatment for thyroid carcinoma.BMJ, 1980
- THE DISTRIBUTION OF RADIOACTIVE IODINE IN HUMAN TISSUES: NECROPSY STUDY IN NINE PATIENTS*The Journal of Clinical Endocrinology & Metabolism, 1950